0001628908-22-000009.txt : 20220207
0001628908-22-000009.hdr.sgml : 20220207
20220207170555
ACCESSION NUMBER: 0001628908-22-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220203
FILED AS OF DATE: 20220207
DATE AS OF CHANGE: 20220207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tutewohl Steve
CENTRAL INDEX KEY: 0001811845
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37415
FILM NUMBER: 22598387
MAIL ADDRESS:
STREET 1: 800 NORTH GLEBE ROAD
STREET 2: SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
FORMER NAME:
FORMER CONFORMED NAME: Tutewohi Steve
DATE OF NAME CHANGE: 20200512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolent Health, Inc.
CENTRAL INDEX KEY: 0001628908
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741]
IRS NUMBER: 320454912
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 NORTH GLEBE RD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
BUSINESS PHONE: 571-389-6000
MAIL ADDRESS:
STREET 1: 800 NORTH GLEBE RD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
4
1
wf-form4_164427153879648.xml
FORM 4
X0306
4
2022-02-03
0
0001628908
Evolent Health, Inc.
EVH
0001811845
Tutewohl Steve
C/O EVOLENT HEALTH, INC.
800 NORTH GLEBE ROAD, SUITE 500
ARLINGTON
VA
22203
0
1
0
0
Chief Operating Officer
Class A Common Stock
2022-02-03
4
S
0
1707
22.85
D
98843
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.39 to $23.61, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
/s/ Jonathan Weinberg, Attorney-in-fact
2022-02-07